Portal de investigación
- Inicio /
- Proyectos y Estudios /
- ENSAYO DE FASE III, ALEATORIZADO, DOBLE CIEGO, MULTICÉNTRICO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE OCTAPLEX, UN CONCENTRADO DE COMPLEJO DE PROTROMBINA DE CUATRO FACTORES (CCP-4F), EN COMPARACIÓN CON EL CCP-4F BERIPLEX® P/N (KCENTRA), PARA LA REVERSIÓ N DE LA ANTICOAGULACIÓN INDUCIDA POR ANTAGONISTAS DE LA VITAMINA K EN PACIENTES QUE REQUIEREN UNA INTERVENCIÓN QUIRÚRGICA DE URGENCIA Y QUE TIENEN UN RIESGO SIGNIFICATIVO DE HEMORRAGIA.
ENSAYO DE FASE III, ALEATORIZADO, DOBLE CIEGO, MULTICÉNTRICO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE OCTAPLEX, UN CONCENTRADO DE COMPLEJO DE PROTROMBINA DE CUATRO FACTORES (CCP-4F), EN COMPARACIÓN CON EL CCP-4F BERIPLEX® P/N (KCENTRA), PARA LA REVERSIÓ N DE LA ANTICOAGULACIÓN INDUCIDA POR ANTAGONISTAS DE LA VITAMINA K EN PACIENTES QUE REQUIEREN UNA INTERVENCIÓN QUIRÚRGICA DE URGENCIA Y QUE TIENEN UN RIESGO SIGNIFICATIVO DE HEMORRAGIA.
Datos básicos
- Protocolo:
- LEX-209
- EUDRACT:
- 2016-002649-41
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2017
- Año de finalización:
- 2021
Objetivos del proyecto
Observaciones: Estado Comité: ACTIVO
Documentos
- No hay documentos
Participantes
-
María Azucena Pajares Moncho
Investigador Principal
Grupos
-
Anestesia y Cuidados Críticos
Investigador Principal
María Azucena Pajares Moncho
Financiadores - Promotores
Resultados del Ensayo Clínico
TRASPLANTE CARDIOPUMLONAR.
MARÍA AZUCENA PAJARES MONCHO, ROSARIO VICENTE GUILLEN, MATILDE PEREZ FERNANDEZ
Capítulo de un Libro. 2018
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
de Andrés-Nogales F; (...); Martínez-Olmos J
Article. 10.1007/s41669-020-00201-2. 2020
A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
Casado, MA; (...); Grp MULTIDEX-EMD
Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
Acute and sustained endothelial damage in COVID-19
Mendez, Raul; (...); Menendez, Rosario
Meeting Abstract. 10.1183/13993003.congress-2021.OA3966. 2021
Acute and sustained increase in endothelial biomarkers in COVID-19.
Méndez R; (...); Menéndez R
Article. 10.1136/thoraxjnl-2020-216797. 2021
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk.
Anguita-Gamez, Maria; (...); Anguita, Manuel
Article. 10.1016/j.rec.2024.09.010. 2024
An unusual intraoperative finding: Left atrial dissecting intramural hematoma after aortic root replacement.
Bernabeu Santisteban R; (...); Argente Navarro P
Article. 10.1016/j.xjtc.2022.03.016. 2022
Analysing criteria for price and reimbursement of orphan drugs in Spain.
Badia, X; (...); Tort, M
Article. 10.7399/fh.11147. 2019
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Analytical Evaluation of ABL90 Flex Plus Blood Gas Analyzer for Urea and Creatinine Multicenter Method Comparison
Sanchez, CP; (...); Soto, AB
Article. 10.1097/POC.0000000000000200. 2020
Anti-endotoxin antibodies consumption in cardiovascular collapse: Pathophysiological concerns.
Villarreal, E.; (...); Vila, J.
Article. 10.1016/j.medine.2022.04.019. 2022
Antimicrobial stewardship programme implementation in a medical ward
Ruiz, J; (...); Poveda, JL
Article. 2018
Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
Ruiz, J; (...); Catellanos, A
Article. 10.1016/j.medin.2017.07.002. 2018
Arterial hypertension in the surgical patient. Medication adequacy and suspension criteria.
Matoses-Jaén MS; (...); Argente-Navarro P
Article. 10.1016/j.redar.2019.11.010. 2020
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Baseline haemoglobin and thromboelastometry are predictive of red blood cell requirements and one-year mortality in liver transplantation.
Viguera L; (...); Sabaté A
Article. 10.1016/j.transci.2021.103259. 2021
Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2018.12.027. 2019
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Can regional cerebral oxygen saturation guide red blood cell transfusion in high risk cardiac surgery?
Garcia, PC; (...); Vicente, R
Article. 10.1016/j.redar.2019.03.013. 2019
Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
Méndez R; (...); Menéndez R
Article. 10.1016/j.chest.2021.10.013. 2021
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
Nogueras, A; (...); Calleja, MA
Letter. 10.1136/ejhpharm-2019-001905. 2019
Collaborative model of home delivery program in haemophilia through an association of patients
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers
Menendez, R; (...); Torres, A
Article. 10.1016/j.chest.2019.06.040. 2019
Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time
Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar
Article. 10.3390/biomedicines12092109. 2024
Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
Megias-Vericat, JE; (...); Poveda, JL
Meeting Abstract. 2020
Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.
Lopez-Vilella, R; (...); Bonet, LA
Article. 10.1016/j.transproceed.2021.08.040. 2021
Consensus document for anaesthesiologist-assisted sedation in interventional cardiology procedures
Martinez-Dolz, L; (...); Alvarez, J
Article. 10.1016/j.redar.2021.01.001. 2021
Consensus document for anaesthesiologist-assisted sedation in interventional cardiology procedures.
Martinez-Dolz, L; (...); Alvarez, J
Article. 10.1016/j.redare.2021.01.001. 2021
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Corrigendum to "Corrigendum to Hydroxyethyl starch and acute kidney injury in high-risk patients undergoing cardiac surgery: A prospective multicenter study" [J Clin Anesth 2021 Oct;73:110367].
Nagore D; (...); Blanco V
Correction. 10.1016/j.jclinane.2021.110436. 2021
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Gironella, M.; (...); Oyaguez, I
Meeting Abstract. 2019
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
Poveda JL; (...); Torres C
Article. 10.1080/14737167.2019.1635014. 2020
COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN
Trillo, JL; (...); Torres, C
Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
COVID-19 thromboprophylaxis. New evidence.
Ferrandis R, Sierra P, Gomez-Luque A
Article. 10.1016/j.redare.2022.11.004. 2023
COVID-19 thromboprophylaxis: New evidences
Ferrandis, R., Sierra, P., Gomez-Luque, A.
Article. 10.1016/j.redar.2022.11.008. 2024
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
Ferrandis, R; (...); Gomez-Luque, A
Letter. 10.1186/s13054-020-03052-9. 2020
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1111/hae.13733. 2019
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
Eduardo Megias, Juan; (...); Iorio, Alfonso
Meeting Abstract. 10.1182/blood-2019-127946. 2019
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Chronic Pulmonary Artery Embolization Models in Large Animals
Aguero, J; (...); Ishikawa, K
Article. 10.1007/978-1-4939-8597-5_28. 2018
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.1080/17512433.2019.1573668. 2019
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
Blade, J; (...); Lizan, L
Article. 10.1136/bmjopen-2017-018850. 2018
Description of Intensive Care and Intermediate Care resources managed by Anaesthesiology Departments in Spain and their adaptation capacity during the COVID-19 pandemic
Medel, G. Tamayo; (...); Fernandez, J. Garcia
Article. 10.1016/j.redar.2023.05.010. 2024
Description of Intensive Care and Intermediate Care resources managed by Anaesthesiology Departments in Spain and their adaptation capacity during the COVID-19 pandemic.
Tamayo Medel, G; (...); Garcia Fernandez, J
Article. 10.1016/j.redare.2024.01.009. 2024
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Alvarez-Roman, MT; (...); Badia, X
Article. 10.1177/2284240319880534. 2019
DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Alvarez, E.; (...); Badia, F. J.
Meeting Abstract. 2019
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
Poveda, J. L.; (...); Vitoria, I
Meeting Abstract. 2019
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
Badia, X; (...); Poved, JL
Article. 10.1080/21678707.2019.1652163. 2019
Diagnosis of intraamniotic inflammation by measuring vaginal interleukin-6 in patients with cervical insufficiency: could amniocentesis be avoided?
Diago Muñoz DM; (...); Diago Almela, Vicente Jose
Article. 10.1080/14767058.2022.2029838. 2022
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan
Ribera, E; (...); Hernandez-Novoa, B
Article. 10.1016/j.eimc.2016.11.015. 2018
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study.
Ferrandis R; (...); Calvo A
Article. 10.1016/j.redare.2023.02.004. 2023
Effects of oxygen on post-surgical infections during an individualised perioperative open-lung ventilatory strategy: a randomised controlled trial
Ferrando, C; (...); iPROVE-O2 Network
Article. 10.1016/j.bja.2019.10.009. 2020
Eficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes críticos con COVID-19: estudio observacional, prospectivo y multicéntrico.
Comes RF; (...); Calvo, A.
Article. 10.1016/j.redar.2022.01.014. 2022
eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Megias-Vericat, JE
Meeting Abstract. 2018
Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.
González-Jiménez P; (...); Méndez R
Article. 10.3390/biomedicines12102413. 2024
Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case-Control Study.
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms241713194. 2023
European guidelines on peri-operative venous thromboembolism prophylaxis: first update.: Chapter 4: Prophylaxis in critical care patients.
Bounes F; (...); Llau JV
Article. 10.1097/EJA.0000000000002011. 2024
European guidelines on perioperative venous thromboembolism prophylaxis: Inferior vena cava filters
Comes, RF; (...); ESA VTE Guidelines Task Force
Article. 10.1097/EJA.0000000000000730. 2018
European guidelines on perioperative venous thromboembolism prophylaxis: Neurosurgery
Faraoni, D; (...); ESA VTE Guidelines Task Force
Article. 10.1097/EJA.0000000000000710. 2018
EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F. J.; (...); Shepherd, J.
Meeting Abstract. 2019
Experience of a fungal infection after cardiac surgery
Vicente-Martinez, L; (...); Argente, P
Article. 10.1016/j.redar.2019.01.012. 2019
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding
Albert-Mari, A; (...); Poveda-Andres, JL
Article. 10.1007/s11096-018-0714-9. 2018
EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
F, de Andres-Nogales; (...); Martinez, M.
Meeting Abstract. 2019
Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplantation in Postinfarction Ventricular Septal Defect
Benavent, Josep Duart; (...); Navarro, Pilar Argente
Meeting Abstract. 2024
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Beltran, B; (...); Nos, P
Article. 10.1159/000492626. 2019
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
Fluid therapy in the surgical patient in our environment. Reporting on the Fluid Day Study
Colomina, MJ; (...); Componentes Comite Ejecutivo Proye
Editorial Material. 10.1016/j.redar.2018.12.007. 2019
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12568. 2017
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units
Article. 10.7399/fh.10935. 2018
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
HEMOMAS-II, an update on the massive hemorrage management
Colomina, M. J., Comes, R. Ferrandis
Editorial Material. 10.1016/j.medin.2023.05.006. 2023
HEMOMAS-II, an update on the massive hemorrhage management.
Colomina, Maria J, Ferrandis Comes, Raquel
Editorial Material. 10.1016/j.medine.2023.05.015. 2023
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
Hyperangulated versus Macintosh blades for intubation with videolaryngoscopy in ICU: the randomised multicentre INVIBLADE-ICU trial study protocol
Taboada, Manuel; (...); Cabaleiro, Teresa
Article. 10.1136/bmjopen-2024-086691. 2024
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL
Article. 10.7399/fh.11262. 2020
Implementation of the Kidney Disease Improving Global Outcomes guidelines for the prevention of acute kidney injury after cardiac surgery: An international cohort survey.
Massoth, Christina; (...); Zarbock, Alexander
Article. 10.1097/EJA.0000000000001837. 2023
Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1159/000478969. 2018
Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy.
Anguita-Gamez, Maria; (...); Marin, Francisco
Article. 10.1016/j.medcli.2024.04.020. 2024
Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Vericat, JEM; (...); Bonanad, S
Meeting Abstract. 2018
Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Bastida, G; (...); Nos, P
Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2017.1323267. 2017
Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.
Ruiz J; (...); Poveda JL
Article. 10.23736/S0026-4946.18.04978-2. 2018
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
Influence of the type of circulatory/ventricular assistance in the primary graft failure and heart transplantation mortality
Vilella, RRL; (...); Bonet, LA
Meeting Abstract. 2018
Initial and Residual Cardiovascular Damage Remaining at Day 30 in Community-acquired Pneumonia
Ocana, R. Mendez; (...); Menendez, R.
Meeting Abstract. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6241. 2024
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12842. 2019
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP
Article. 10.1136/ejhpharm-2020-002322. 2020
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
Left side clot in transit in double-lung transplantation diagnosticated by transesophageal echocardiography: what's next?
Perez-Ajami, D; (...); Argente Navarro, P
Case Reports. 10.1016/j.redare.2023.12.001. 2023
Left side clot in transit in double-lung transplantation diagnosticated by transesophageal echocardiography: What's next?
Perez-Ajami, D.; (...); Navarro, E. Viscasillas
Article. 10.1016/j.redar.2023.03.006. 2024
Letter to the Editor'' response to Vives and Devereaux
Ferrandis, R.; (...); Llau, J. V.
Letter. 10.1016/j.redar.2021.11.003. 2022
Liver transplant with controlled donors after circulatory death with normothermic regional perfusion and brain dead donors: A multicenter cohort study of transfusion, one-year graft survival and mortality.
Viguera L; (...); Sabaté A
Article. 10.1016/j.ijsu.2021.106169. 2021
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey.
Ferrandis R; (...); Samama CM
Letter. 10.1016/j.bja.2021.06.041. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Massive Primary Mitral Regurgitation Due to Chordae Rupture: Treatment With New-Generation Edge-to-Edge Repair Devices.
Vilchez-Tschischke JP; (...); Diez-Gil JL
Editorial Material. 10.1016/j.jcin.2020.12.026. 2021
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
Modeling Pulmonary Hypertension: A Pig Model of Postcapillary Pulmonary Hypertension
Bikou O; (...); Aguero J
Article. 10.1007/978-1-4939-8597-5_29. 2018
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.
Fernandez-Megia, MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.10793. 2018
Multicentric survey on the use of intraoperative echocardiography in cardiovascular surgery in Spain.
Carmona García P; (...); Argente Navarro P
Article. 10.1016/j.redar.2020.07.012. 2020
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National survey on perioperative monitoring of direct oral anticoagulants: MonACOD survey.
Igualada J; (...); Llau JV
Letter. 10.1016/j.redare.2024.04.014. 2024
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms24076690. 2023
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
Observational study on fluid therapy management in surgical adult patients.
Colomina MJ; (...); Peñafiel J
Article. 10.1186/s12871-021-01518-z. 2021
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Off-Pump Coronary Artery Bypass Grafting and Transaxillary Aortic Valve Implantation in Porcelain Aorta Through Minimally Invasive Cardiac Surgery
Sole Sabau, Miguel; (...); Argente Navarro, Maria Pilar
Meeting Abstract. 2024
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Poveda, JL
Meeting Abstract. 2018
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Patient blood management in cardiac surgery: Results.
Pajares, A; (...); Argente, P
Article. 10.1016/j.redar.2017.11.008. 2018
Patient Blood Management: A conceptual and analytical vision from the leadership in Spain.
Mendez-Arias, E; (...); Colomina, M J
Article. 10.1016/j.redare.2024.501650. 2024
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU.
Vivas D; (...); Ferreiro JL
Article. 10.1016/j.rec.2018.01.029. 2018
Perioperative colloids: From theory to practice
Pinillos, J. L. Jover; (...); Soler, M. J. Colomina
Article. 10.1016/j.redar.2022.03.001. 2023
Perioperative colloids: From theory to practice.
Jover Pinillos JL; (...); Colomina Soler MJ
Article. 10.1016/j.redare.2022.03.002. 2023
Perioperative management of the patients with hip fracture under anticoagulant or antiaggregants treatment. Consensus recommendations from the hemostasis section of SEDAR.
Cassinello, C; (...); Sierra, P
Article. 10.1016/j.redare.2024.501651. 2024
Perioperative transfusion management in craniotomies: a national survey, a starting point for the evaluation of improvements in health care.
Hurtado, P; (...); Fernandez-Candil, J
Article. 10.1016/j.redare.2024.501661. 2024
Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry.
Ferrandis R; (...); Sabaté S
Article. 10.1055/s-0040-1712476. 2020
Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties?
Anguita-Gámez M; (...); Anguita Sánchez M
Article. 10.1016/j.rec.2024.02.017. 2024
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy
Margusino-Framiñán L; (...); Morillo-Verdugo R
Article. 10.7399/fh.11498. 2020
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.2174/1389200218666171101124931. 2018
Pharmacokinetics of micafungin in patients treated with extracorporeal membrane oxygenation: an observational prospective study.
López-Sánchez M; (...); Argente-Navarro MP
Article. 10.5935/0103-507x.20200044. 2020
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Pilot evaluation of home delivery programme in haemophilia
Megias-Vericat, JE; (...); Poveda-Andres, JL
Article. 10.1111/jcpt.12718. 2018
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
Vericat, JEM; (...); Iorio, A
Meeting Abstract. 2020
Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process
Valero, S; (...); Poveda, JL
Article. 10.1016/j.yrtph.2018.03.001. 2018
Predictive Value of First Amniotic Sac IL-6 and Maternal Blood CRP for Emergency Cerclage Success in Twin Pregnancies.
Diago-Munoz, Diana Maria; (...); Diago-Almela, Vicente Jose
Article. 10.3390/jpm15010037. 2025
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Preoperative Coagulation Tests: A narrative review of current guidelines
Pinillos, J. L. Jover; (...); Colomina, Maria J.
Article. 10.1016/j.redar.2024.06.002. 2024
Preoperative coagulation tests: A narrative review of current guidelines.
Jover Pinillos, J L; (...); Colomina Soler, M J
Article. 10.1016/j.redare.2024.09.005. 2024
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in real-world patients: the REQXAA study.
Vivas, David; (...); Marind, Francisco
Article. 10.1016/j.rec.2023.03.003. 2023
Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker
Perez-Alenda, S; (...); Querol, F
Letter. 10.1111/hae.13388. 2018
Quantitative Transthoracic Echocardiography of the Response to Dobutamine in Cardiac Surgery Patients With Low Cardiac Output Syndrome.
Zarragoikoetxea I; (...); Aguero J
Article. 10.1053/j.jvca.2019.08.019. 2020
Recommendations for perioperative antiplatelet treatment in non-cardiac surgery. Working Group of the Spanish Society of Anaesthesiology-Resuscitation and Pain Therapy, Division of Haemostasis, Transfusion Medicine, and Perioperative Fluid Therapy. Update of the Clinical practice guide 2018
Sierra, P; (...); Hidalgo, F
Review. 10.1016/j.redar.2018.07.003. 2019
Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines.
Kietaibl, Sibylle; (...); Afshari, Arash
Article. 10.1097/EJA.0000000000001600. 2022
Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension
Watanabe, S; (...); Hajjar, RJ
Article. 10.1177/2045894018799738. 2018
Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial
Garg, AX; (...); Perioperative Anesthesia Clinical
Article. 10.1681/ASN.2019010004. 2019
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
Article. 10.1111/ajt.14580. 2018
SEDAR/SECCE ECMO management consensus document
Zarragoikoetxea, I; (...); Guillen, RV
Article. 10.1016/j.redar.2020.12.011. 2021
SEDAR/SECCE ECMO management consensus document.
Zarragoikoetxea I; (...); Vicente Guillén R
Practice Guideline. 10.1016/j.redare.2020.12.002. 2021
SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients
Llau, J. V.; (...); Marcos, P.
Letter. 2020
SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients.
Llau JV; (...); Marcos P
Letter. 10.1016/j.medin.2020.08.007. 2021
SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients.
Llau JV; (...); Marcos P
Letter. 10.1016/j.medine.2021.10.007. 2021
SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection
Llau, JV; (...); Marcos, P
Article. 10.1016/j.redar.2020.05.007. 2020
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
Simultaneous Depression of Immunological Synapse and Endothelial Injury is Associated with Organ Dysfunction in Community-Acquired Pneumonia
Menendez, R; (...); Bermejo-Martin, JE
Article. 10.3390/jcm8091404. 2019
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact ofPseudomonas aeruginosa
MENENDEZ, R; (...); Torres, A
Article. 10.3390/jcm9082631. 2020
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus
Torrent-Farnell, J; (...); Lizan, L
Article. 10.1016/j.healthpol.2018.03.002. 2018
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Marques MR; (...); Mangas-Sanjuan V
Article. 10.1111/apa.14944. 2020
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Tranexamic acid in cardiac surgery: Are low doses enough?
Peña Borras JJ; (...); en representación del grupo de trabajo de hemostasia en cirugía cardíaca del Con
Article. 10.1016/j.redar.2021.02.008. 2021
Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Bejar, S; (...); Mateu, PN
Meeting Abstract. 2020
Update on the use of ultrasound in the diagnosis and monitoring of the critical patient
Rodenas Monteagudo, M. A.; (...); Zarragoikoetxea Jauregui, I
Article. 10.1016/j.redar.2022.01.005. 2022
Update on the use of ultrasound in the diagnosis and monitoring of the critical patient.
Ródenas Monteagudo MÁ; (...); Zarragoikoetxea Jauregui I
Article. 10.1016/j.redare.2022.01.003. 2022
Uric Acid and acute kidney injury in high-risk patients for developing Acute Kidney Injury undergoing cardiac surgery: a prospective multicenter study.
Nagore, D; (...); Blanco, V
Article. 10.1016/j.redare.2024.04.019. 2024
Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy
Garcia, SV; (...); Andres, JLP
Article. 10.1016/j.yrtph.2018.10.002. 2018
USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Dominguez Hernandez, L.; (...); Gomez Segui, I
Meeting Abstract. 2019
Use of Dexmedetomidine in Cardiothoracic and Vascular Anesthesia
Gallego-Ligorit, L; (...); Iglesias, M
Review. 10.1053/j.jvca.2017.11.044. 2018
Usefulness of biomarkers to predict prognosis after heart transplant
Lopez-Vilella, Raquel; (...); Boneta, Luis Almenar
Article. 10.1016/j.rec.2024.04.019. 2024
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
What is a low low-molecular-weight heparin dose?
Godier, Anne; (...); Langenecker, Sibylle
Article. 10.1097/EJA.0000000000001962. 2024